Health Outcomes of Recently Diagnosed Myelodysplastic Syndrome (MDS)/Chronic Myelomonocytic Leukemia (CMML) Patients Depending on Treatment Strategy (Wait and See, Support, Active Treatment)

Conditions

• Myelodysplastic Syndrome
• Leukemia, Myelomonocytic, Chronic

Interventions

• OTHER: Either Wait and See, or Supportive Treatment, or Active Treatment at physician discretion

Sponsor

Celgene